<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03708068</url>
  </required_header>
  <id_info>
    <org_study_id>REB18-0772</org_study_id>
    <nct_id>NCT03708068</nct_id>
  </id_info>
  <brief_title>Early Exclusive Enteral Nutrition in Early Preterm Infants</brief_title>
  <official_title>Early Exclusive Enteral Nutrition in Stable Preterm Infants at 30 0/7 - 33 6/7 Weeks Gestation: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Belal Alshaikh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Calgary</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Enteral nutrition in preterm infants is usually started and advanced slowly until reaching&#xD;
      full enteral feeds. Most preterm infants born before 34 weeks gestation require parenteral&#xD;
      fluids to maintain normal blood sugar level and prevent excessive weight loss and&#xD;
      dehydration. Availability of donor human milk (DHM) along with low incidence of necrotizing&#xD;
      enterocolitis (NEC) in preterm infants born at 30-33 weeks have encouraged neonatologists to&#xD;
      start feeding early and advance it faster in order to shorten time on parenteral nutrition&#xD;
      (PN) and minimize the need for intravenous access. The objectives of this trial is to study&#xD;
      whether exclusive enteral nutrition from day of birth (i.e. no PN) results in shorter time to&#xD;
      achieve full enteral feed when compared with traditional feeding regimen that involves a&#xD;
      combination of PN and progressive enteral feeding.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Early nutritional support of preterm infants born at 30-33 weeks gestation is usually&#xD;
      achieved via a combination of parenteral nutrition (PN) and enteral feeding that is advanced&#xD;
      over few days to reach full enteral feed. Recent studies suggest that rapid increase of&#xD;
      enteral feed volumes results in shorter duration on PN and earlier achievement of full&#xD;
      enteral feed without increasing the risk of necrotizing enterocolitis (NEC) or death.&#xD;
      Although PN has an important role in nutrition of preterm infants, it is associated with&#xD;
      increased risk of metabolic and infectious complications even when it is used for a short&#xD;
      period of time. Furthermore, PN mandates the need for peripheral or central intravenous&#xD;
      access. Provision of full enteral feed volume that meets reference daily fluid intake from&#xD;
      day of birth is used frequently and successfully in stable preterm infants born after 33&#xD;
      weeks. Expanding the use of this regimen to stable preterm infants born at 30-33 weeks&#xD;
      gestation may help avoid unnecessary start of intravenous access, prevent complications&#xD;
      related to PN, and encourage mother-infant bonding experience.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 16, 2019</start_date>
  <completion_date type="Anticipated">November 2022</completion_date>
  <primary_completion_date type="Anticipated">November 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration to achieve of full enteral feeds in days</measure>
    <time_frame>Till 30 days of life</time_frame>
    <description>Day of life to achieve full enteral feeding defined as 140 ml/kg/day which is sustained for at least 3 days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>At discharge from neonatal intensive care unit (NICU), up to 90 days of life</time_frame>
    <description>Length of hospital stay in days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Feeding intolerance</measure>
    <time_frame>Till 30 days of life</time_frame>
    <description>Presence of one or more of the following:&#xD;
vomiting more than 2 times during any 24 h period,&#xD;
any episode of bile- or blood-stained vomiting,&#xD;
abdominal wall erythema or tenderness that resulted in cessation of feed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of late onset sepsis</measure>
    <time_frame>At discharge from NICU, up to 90 days of life</time_frame>
    <description>Any microbial growth in blood, cerebrospinal fluid or urine after 72 hours of admission in NICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of NEC</measure>
    <time_frame>At discharge from NICU, up to 90 days of life</time_frame>
    <description>Any Stage II and above according to Bell's staging criteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of hypoglycemia</measure>
    <time_frame>Till 30 days of life</time_frame>
    <description>Defined as point of care testing Glucose &lt; 2.6 mmol/L at any time after rollment in study</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">68</enrollment>
  <condition>Enteral Nutrition</condition>
  <arm_group>
    <arm_group_label>Early Exclusive Enteral Nutrition</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Feeds will start at least at 80% of reference daily fluid intake from day one of life.&#xD;
Feeds will be advanced by 20-30 ml/kg per day on second day onwards until infant reaches full enteral feed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional Enteral Nutrition</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Infants will be fed as per current Neonatal Intensive Care Unit feeding tables:&#xD;
Infants with birth weight 1000-1500 g will be fed on 15-20 ml/kg human milk in day one. Feeds will be advanced by 15-20 ml/kg per day on second day onwards until infant reaches full enteral feeds.&#xD;
Infants with birth weight &gt;1500 g will be started on 20-30 ml/kg per day on day one. Feeds will be advanced by 20-30 ml/kg per day on second day onwards until infant reaches full enteral feeds.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Early exclusive enteral nutrition</intervention_name>
    <description>Infants will be fed at least 80% of reference daily fluid intake from day one. Feeds will be advanced by 20-30 ml/kg per day on second day onwards to meet reference daily fluid intake until infant reaches full enteral feed.</description>
    <arm_group_label>Early Exclusive Enteral Nutrition</arm_group_label>
    <other_name>Early Total Enteral Feed</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Preterm infants born at 30 0/7 - 33 6/7 weeks gestation&#xD;
&#xD;
          2. Birth weight greater than 1000 g&#xD;
&#xD;
          3. Consent to use donor human milk&#xD;
&#xD;
          4. Postnatal age is less than 48 hours from birth&#xD;
&#xD;
          5. Infant is ready to start on feeding (as per clinical team) or feeding volume, when&#xD;
             already started, is ≤12 ml/kg per day (total) and/or the infant received ≤2 feeds&#xD;
             based on current feeding policy or physician descrition (total volume of the received&#xD;
             feeds is ≤20 ml/kg per day).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Cord PH &lt; 7.00 or Cord base access (BE) &lt; -16&#xD;
&#xD;
          2. Apgar score &lt; 7 at 5 minute&#xD;
&#xD;
          3. Lactate level ≥3 (if done for clinical indication)&#xD;
&#xD;
          4. Need for positive pressure ventilation (PPV) for &gt;1 minute.&#xD;
&#xD;
          5. Hemodynamic instability (hypotension or poor perfusion at any time in this 48 hours)&#xD;
&#xD;
          6. Small for gestational age &lt;3 percentile on Fenton chart and/or fetal absent or&#xD;
             reversed umbilical arterial end-diastolic blood flow.&#xD;
&#xD;
          7. Major congenital malformation&#xD;
&#xD;
          8. Symptomatic or severe hypoglycemia (blood glucose &lt;1.8 mmol/L)&#xD;
&#xD;
          9. Infants with moderate to severe respiratory distress.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>48 Hours</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Belal Alshaikh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Calgary</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Belal Alshaikh, MD</last_name>
    <phone>403-956-1588</phone>
    <email>balshaik@ucalgary.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wissam Alburaki, MD</last_name>
    <phone>4034838903</phone>
    <email>w.alburaki@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Peter Lougheed Hospital</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T1Y6J4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Belal Alshaikh, MD</last_name>
    </contact>
    <investigator>
      <last_name>Essa Al Awad, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nalini Singhal, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Foothills Medical Centre</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N2T9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Belal Alshaikh, MD</last_name>
    </contact>
    <investigator>
      <last_name>Belal Alshaikh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dinesh Dharel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rockyview General Hospital</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2V1P9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Belal Alshaikh, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jeanne Scotland, NNP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>South Health Campus</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T3M1P9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Belal Alshaikh, MD</last_name>
    </contact>
    <investigator>
      <last_name>Belal Alshaikh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ruma Jain, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>October 1, 2018</study_first_submitted>
  <study_first_submitted_qc>October 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 16, 2018</study_first_posted>
  <last_update_submitted>September 9, 2021</last_update_submitted>
  <last_update_submitted_qc>September 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Calgary</investigator_affiliation>
    <investigator_full_name>Belal Alshaikh</investigator_full_name>
    <investigator_title>Neonatologist</investigator_title>
  </responsible_party>
  <keyword>Exclusive</keyword>
  <keyword>Enteral Nutrition</keyword>
  <keyword>Preterm Infant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

